A cohort study examines whether the use of common medications was associated with worse outcomes in patients with lung cancer taking immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results